Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival - Concepedia

Concepedia

Publication | Open Access

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

DOI Full Paper Access

777

Citations

62

References

2012

Year

Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Romuald Zdrojowy, Cezary Szczylik, Michael Staehler, Wolfram Brugger, Pierre-Yves Dietrich, Regina Mendrzyk, Norbert Hilf,

Nature Medicine

VaccinationCancer ImmunosurveillanceMultipeptide Immune ResponseMedicineCancer Vaccine Ima901ImmunologyTumor ImmunityTherapeutic VaccineImmune Checkpoint InhibitorImmunotherapeuticsSingle-dose CyclophosphamideVaccine DesignImmunotherapyOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1